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Abstract 
Background 
In intensive care, weaning is the term used for the process of withdrawal of mechanical 
ventilation to enable spontaneous breathing to be re-established. Inspiratory muscle weakness 
and deconditioning are common in patients receiving mechanical ventilation, especially that 
of prolonged duration. Inspiratory muscle training could limit or reverse these unhelpful 
sequelae and facilitate more rapid and successful weaning.  
Findings 
This review will involve systematic searching of five electronic databases to allow the 
identification of randomised trials of inspiratory muscle training in intubated and ventilated 
patients. From these trials, we will extract available data for a list of pre-defined outcomes, 
including maximal inspiratory pressure, the duration of the weaning period, and hospital 
length of stay. We will also meta-analyse comparable results where possible, and report a 
summary of the available pool of evidence. 
Discussion 
The data generated by this review will be the most comprehensive answer available to the 
question of whether inspiratory muscle training is clinically useful in intensive care. As well 
as informing clinicians in the intensive care setting, it will also inform healthcare managers 
deciding whether health professionals with skills in respiratory therapy should be made 
available to provide this sort of intervention. Through the publication of this protocol, readers 
will ultimately be able to assess whether the review was conducted according to a pre-defined 
plan. Researchers will be aware that the review is underway, thereby avoid duplication, and 
be able to use it as a basis for planning similar reviews. 
Findings 
Introduction 
Mechanical ventilation temporarily replaces or supports spontaneous breathing in patients 
with critical illness or requiring post-operative support in an intensive care unit (ICU). 
Weaning is the term used for the process of withdrawal of mechanical ventilation to enable 
spontaneous breathing to be re-established. Patients are considered to be successfully weaned 
from ventilatory support when they can breathe on their own for at least 48 hours [1]. Almost 
70% of ICU patients proceed from initiation of weaning to successful extubation without 
difficulty on the first attempt [2]. Other patients have a more difficult or prolonged period of 
weaning, which is associated with a poorer prognosis [3,4]. The weaning process typically 
comprises 40 to 50% of the total duration of mechanical ventilation [2]. Despite representing 
only a small percentage of ICU patients, those who fail to wean from ventilation consume a 
disproportionate share of resources [1]. 
 
Weaning failure resulting in prolonged ventilation is detrimental to the individual as it is 
associated with increased risk of respiratory muscle weakness, critical illness 
myopathy/polyneuropathy (CIM/CIP), nosocomial infection and airway trauma [2,5]. 
Prolonged ventilation is also associated with an increase in mortality, morbidity and ICU 
length of stay, as well as reduced functional status and quality of life [5-7]. In addition 
prolonged ventilation is expensive, consuming a large fraction of hospital resources, with a 
healthcare burden that may continue after hospital discharge [8]. 
 
Weakness or fatigue of the diaphragm and accessory muscles of inspiration is widely 
recognised as a cause of failure to wean from mechanical ventilation [6,9]. Fatigue may be 
due to excessive load on the inspiratory muscles, which may result from increased airway 
resistance and/or reduced lung compliance. A reduction in the capacity of the respiratory 
muscle pump may also occur due to phrenic nerve injury, CIM/CIP, corticosteroids, 
endocrine or nutritional factors [7]. There is increasing evidence to show mechanical 
ventilation itself may adversely affect the diaphragm's structure and function, which has been 
termed ventilator-induced diaphragmatic dysfunction [9]. The combination of positive 
pressure ventilation and positive end-expiratory pressure may unload the diaphragm therefore 
subjecting it to changes in myofibre length, which may account for its rapid atrophy [9]. In 
addition, patients who undergo prolonged periods of ventilation demonstrate a decrease in 
respiratory muscle endurance and are at risk of respiratory muscle fatigue [10]. 
 
Inspiratory muscle training (IMT) is a technique that targets the muscles of inspiration - 
namely the diaphragm and accessory inspiratory muscles - with the aim of increasing 
inspiratory muscle strength and endurance. In ventilated patients, IMT can be undertaken in 
several ways: isocapnic / normocapnic hyperpnoea training, resistive flow training, threshold 
pressure training, or adjustment of the ventilator to provide a training load for the inspiratory 
muscles. 
 
Isocapnic/normocapnic hyperpnoea. Belman [11] first reported training the respiratory 
muscles using isocapnic hyperpnoea to increase inspiratory muscle endurance and facilitate 
weaning. This is a method of respiratory muscle endurance training, during spontaneous 
breathing or mechanical ventilation, in which the patient voluntarily breathes at high levels of 
ventilation for a sustained period of time, generating a low-pressure high-flow load. This 
would normally result in hypocapnia but normal PaCO2 levels are maintained by entraining 
CO2 into the inspiratory limb of the ventilator circuit. Normocapnic hyperpnoea is not 
commonly used in clinical practice due to the complexity of the equipment required to 
maintain CO2 homeostasis [12]. 
 Inspiratory resistive flow training. Abelson and Brewer [13] and Aldrich et al [14] first 
reported using inspiratory resistive training to attempt to increase inspiratory muscle strength 
and facilitate weaning from mechanical ventilation. This method involves attaching the IMT 
device via a connector or adaptor to the endotracheal or tracheostomy tube [13]. This makes 
the patient inhale through an orifice with a reduced diameter, which in turn places an 
increased load on the inspiratory muscles. The amount of inspiratory resistance is dependent 
on the flow generated by the patient, which may be variable if the breathing pattern is not 
regulated. 
 
Inspiratory threshold pressure training. In threshold pressure training, a specific negative 
threshold pressure has to be reached before a spring-loaded valve opens to allow inspiratory 
flow. The pressure is not influenced by patients modifying their breathing pattern. The IMT 
device is incorporated into the ventilator circuit with an adaptor or connector. Case reports 
have described the use of inspiratory pressure threshold training in an attempt to increase 
inspiratory muscle strength in ventilated patients which was followed by increases in the 
duration of periods of unassisted breathing [1,15,16]. 
 
Adjustment of ventilator sensitivity. It is possible to alter the ventilator sensitivity to 
provide resistance and hence a pressure load to the inspiratory muscles. By progressively 
adjusting the pressure trigger sensitivity, the inspiratory load can be gradually increased. This 
is typically based on a percentage of the maximal inspiratory pressure (MIP) [17]. 
 
Inspiratory muscles respond to training in the same way as other skeletal muscles in regard to 
the principles of overload, specificity and reversibility [18]. In healthy people and in people 
with chronic obstructive pulmonary disease, IMT increases respiratory muscle strength and 
endurance [19-22]. The effectiveness of IMT in increasing inspiratory muscle strength and 
endurance in ventilated patients (to potentially reduce weaning duration) has not yet been 
established. In patients who have failed to wean from mechanical ventilation using standard 
weaning techniques, several case reports have demonstrated increases in inspiratory muscle 
strength measured by maximal inspiratory pressure (MIP) after IMT, followed by successful 
weaning [1,13,14]. Sprague et al [1] hypothesised that IMT may work to assist patients in 
weaning from ventilation by any of the following mechanisms: 
1. improving the function of the respiratory muscle pump via changes in muscle fibre type, 
size and physiological efficiency, 
2. improving the activation of the respiratory muscle pump via the adaptation of neural 
pathways to allow more efficient motor unit recruitment, and 
3. improving the breathing pattern. 
Improving the strength and endurance of the inspiratory muscles may therefore reduce 
ventilator dependence over time and facilitate spontaneous breathing. Reducing ventilation 
time may help to reduce the incidence of ventilator-associated complications and may 
decrease ICU and hospital length of stay. 
 
To date there are no systematic reviews evaluating the effectiveness of IMT in facilitating 
weaning from mechanical ventilation. By increasing inspiratory muscle strength and 
endurance, IMT may have the potential to reduce the duration of mechanical ventilation and 
so decrease associated complications and costs and improve patient outcomes. 
 
One aim of this systematic review is to evaluate the effectiveness of IMT in increasing 
inspiratory muscle strength and endurance in mechanically ventilated patients. A further aim 
is to determine whether IMT affects the duration of weaning from mechanical ventilation, the 
duration of unassisted breathing periods during the weaning period, and the rate of 
reintubation. 
 
Methods 
Inclusion criteria for studies in the review  
Types of studies:  Eligible studies will be randomised controlled trials and quasi-randomised 
controlled trials. Only the first arm of cross-over trials will be included. 
Types of participants:  Eligible participants will be adults (16 years and over) who are 
intubated or tracheostomised and are receiving full or partial mechanical ventilation. 
Types of interventions:  Inspiratory muscle training including isocapnic / normocapnic 
hyperpnoea, inspiratory resistive flow training (e.g. with Pflex brand), threshold pressure 
loading (e.g. with Threshold brand), or adjustment of the ventilator sensitivity, compared with 
sham or no IMT. 
Types of outcome measures:   
Primary Outcomes 
1. Measures of inspiratory muscle strength, such as maximal inspiratory pressure (MIP), if 
lung volume during the measurement of MIP is controlled 
2. Measures of inspiratory muscle endurance, such as sustained MIP or MIP load 
3. Duration of unassisted breathing periods after commencement of IMT 
4. Weaning duration from the identification of readiness to wean (as determined by the 
authors and/or commencement of IMT) to the discontinuation of mechanical ventilation 
5. Weaning success (proportion of patients successfully weaned, defined as spontaneous 
breathing without mechanical support for at least 48 hours) 
6. Reintubation (proportion of extubated patients who were reintubated within the follow-up 
period of the study) 
Secondary outcomes  
1. Tracheostomy (proportion of patients tracheostomised) after commencement of IMT or 
no/sham IMT 
2. ICU length of stay 
3. Hospital length of stay 
4. Mortality 
5. Adverse events 
 
Search Strategy 
The following databases will be electronically searched for all available years: PEDro, 
CENTRAL, PubMed, EMBASE and CINAHL. The search will not be limited by date, 
language or publication status. We will check the reference lists of any eligible studies 
identified for further relevant studies. We will also ask authors of eligible trials and 
manufacturers of IMT devices if they know of other eligible studies. Translation of foreign 
language trials will be performed by the authors for Dutch and German (NV) and Italian 
(ME), or by commercial translators for other languages.  
 
PEDro Search Strategy 
1. inspirat* musc* train* in Abstract & Title field 
2. respirat* musc* train* in Abstract & Title field 
3. respirat* musc* condit* in Abstract & Title field 
4. resist* load* in Abstract & Title field 
5. press* thresh* load* in Abstract & Title field 
6. incre* thresh* load* in Abstract & Title field 
 
CENTRAL Search Strategy 
1. ((muscu* OR muscl*) NEAR/15 (train* OR condition*) NEAR/15 (inspirat* OR ventilat* 
OR respirat* OR pulmonary)):ti,ab,kw in Clinical Trials 
2. ((isocapn* OR normocapn*) NEAR/5 (hyperpn*)):ti,ab,kw in Clinical Trials 
3. ((inspirat*) NEAR/5 (resist*) NEAR/5 (load*)):ti,ab,kw in Clinical Trials 
4. ((pressure) NEAR/5 (threshold) NEAR/5 (load*)):ti,ab,kw in Clinical Trials 
5. (p-flex):ti,ab,kw in Clinical Trials 
6. (#1 OR #2 OR #3 OR #4 OR #5) 
7. "intensive care":ti,ab,kw in Clinical Trials 
8. ((critical*) AND (care OR ill*)):ti,ab,kw in Clinical Trials 
9. (intubat* OR ventilat* OR tracheostom*):ti,ab,kw in Clinical Trials 
10. (#7 OR #8 OR #9) 
11. (#6 AND #10) 
 
PubMed Search Strategy 
1. randomized controlled trial[Publication Type] 
2. controlled clinical trial[Publication Type] 
3. randomi*ed[Title/Abstract] 
4. placebo[Title/Abstract] 
5. "clinical trials as topic"[MeSH Major Topic] 
6. randomly[Title/Abstract] 
7. trial[Title] 
8. #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 
9. (muscu* OR muscl*) AND (train* OR condition*) AND (inspirat* OR respirat* OR 
ventilat* OR pulmonary) 
10. (isocapn* OR normocapn*) AND (hyperpn*) 
11. (inspirat* AND resist* AND load*) 
12. (pressure AND threshold AND load*) 
13. p-flex 
14. #9 OR #10 OR #12 OR #13  
15. "intensive care"[Title/Abstract] 
16. (critical*[Title/Abstract] AND (care[Title/Abstract] OR ill[Title/Abstract] OR 
illness[Title/Abstract]))  
17. intubat*[Title/Abstract] OR ventilat*[Title/Abstract] OR tracheostomi*[Title/Abstract] 
18. #15 OR #16 OR #17 
22. #8 AND #14 AND #18 
 
EMBASE Search Strategy 
1. ‘intensive care’/exp 
2. ‘critically ill’/exp 
3. ‘artificial ventilation’/exp 
4. #1 OR #2 OR #3 
5. 'breathing exercise'/exp  
6. 'breathing muscle'/exp  
7.  #5 OR #6  
8. #4 AND #7 
9. #8 AND ([controlled clinical trial]/lim OR [randomized controlled trial]/lim) AND 
[humans]/lim 
 CINAHL Search Strategy 
1. randomized controlled trial [Publication Type] 
2. controlled clinical trial [Publication Type] 
3. clinical trials [Exact Major Subject Heading] 
4. random$ [Title] 
5. randomly [Abstract] 
6. trial [Title] 
7. #1 OR #2 OR #3 OR #4 OR #5 OR #6  
8. (muscu* OR muscl*) AND (train* OR condition*) AND (inspirat* OR respirat* OR 
ventilat* OR pulmonary) [Abstract] 
9. (isocapn* OR normocapn*) AND (hyperpn*) [Abstract] 
10. (inspirat* AND resist* AND load*) [Abstract] 
11. (pressure AND threshold AND load*) [Abstract] 
12. p-flex [Abstract] 
14. #8 OR #9 OR #10 OR #11 OR #12 
15. intensive care  [Exact Major Subject Heading] 
16. #7 AND #14 AND #15 
 
Two authors will independently review all potential studies for inclusion against the eligibility 
criteria. They will examine the title and abstract and, where necessary, the full text of studies 
to assess if they are eligible for inclusion. If they cannot reach agreement by discussion, a 
third author will make the final decision re eligibility. 
 
Data extraction 
Two authors will independently use a standard form to extract study characteristics and 
outcome data from the studies. Discrepancies will be checked against the original data. A 
third author will make the final decision if there is a disagreement. LM will enter data in 
Revman meta-analysis software [23]. We will report data during intubation, at extubation 
from mechanical ventilation, within 2 days of extubation, at discharge from ICU, more than 2 
days since extubation but before discharge from hospital, and at discharge from hospital. Any 
outcomes measured after discharge from hospital will be grouped as less than 1 month, 1 to 6 
months, and over 6 months. 
 
Quality assessment 
Methodological quality will be assessed using the PEDro scale [24,25] by a trained assessor 
(ME). Scores will be based on all information available from both the published version and 
the authors themselves. No trial will be excluded on the basis of poor quality. 
 
Data analysis 
For binary (dichotomous) outcome measures, we aim to calculate a pooled estimate of 
treatment effect for each outcome across studies using risk ratio where appropriate and the 
corresponding 95% confidence intervals (CIs). For continuous outcome measures, we will 
calculate a pooled estimate of treatment effect by calculating the mean difference and the 
corresponding 95% CIs. When analysing count data, a decision will be made whether to treat 
these as dichotomous, continuous, time-to-an-event or as a rate depending on whichever of 
these methods allows the greatest number of data points to be included in the meta-analysis. 
We plan to analyse time-to-event data using the hazard ratio and 95% CIs. When conducting a 
meta-analysis combining results from crossover studies, we plan to use the first-arm data 
only. In the event of missing, incomplete, or unclear data we plan to contact the original 
investigators. If we do not obtain the necessary data for analysis, we will describe the study 
results in the text.  
 
We plan to assess the degree of heterogeneity between studies using the I2 statistic [26]. This 
measure describes the percentage of total variation across studies that are caused by 
heterogeneity rather than by chance [26]. The values of I2 lie between 0% and 100%, and a 
simplified categorisation of heterogeneity that we plan to use is low (I2 value of less than 
25%), moderate (I2 value of between 25 and 50%), and high (I2 value of over 50%) [26]. If 
sufficient studies are included we will assess reporting bias among the studies using the 
funnel plot method discussed in the Cochrane Handbook for Systematic Reviews of 
Interventions [26]. If asymmetry is present, we will explore possible causes including 
publication bias, methodological quality, and true heterogeneity. We will enter data extracted 
from included studies into RevMan software [23]. If there is no significant heterogeneity, we 
will compute pooled estimates of the treatment effect for each outcome under a fixed-effect 
model. If there is significant heterogeneity, we will compute pooled estimates of the treatment 
effect for each outcome using a random-effects model. 
If there is significant heterogeneity (over 50%) and there are sufficient studies included in the 
review, we will investigate the possible causes further by performing the following subgroup 
analyses: 
Isocapnic/ normocapnic hyperpnoea  
Inspiratory resistive flow training  
Inspiratory threshold pressure training  
Adjustment of ventilator sensitivity  
Strength regimens  
Endurance regimens  
Anticipated to fail weaning prior to commencement of IMT, according to any objective 
criteria used by authors  
Ventilator dependent (having failed at least one previous weaning attempt) prior to 
commencement of IMT  
Duration of ventilation prior to starting IMT 
 
Sensitivity analysis  
We will test the robustness of our results through sensitivity analyses excluding unpublished 
studies, small studies, and studies with a PEDro score less than 5. 
 
Discussion and Conclusion 
This review aims to provide comprehensive evidence of the effectiveness of IMT at 
improving inspiratory muscle strength and facilitating weaning in patients who are intubated 
and mechanically ventilated. This will inform physiotherapists, respiratory therapists and 
other clinicians in the intensive care setting. It will also inform policy makers and healthcare 
commissioners in deciding whether health professionals with skills in respiratory therapy 
should be made available to provide this sort of intervention. Through the publication of this 
protocol, readers will be able to assess whether the review was conducted according to a pre-
defined plan. Researchers will be aware that the review is underway, and thereby avoid 
duplication. Researchers will also be able to use it as a basis for planning similar reviews. 
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